Koutif Therapeutics
PrivateLast Round
Accelerator
Sep 21, 2017
Company Overview
Koutif Therapeutics is a biotechnology company that develops therapeutic compounds targeting the ubiquitin degradation pathway to treat various inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Koutif Therapeutics Comparables
Compare Koutif Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kymera Therapeutics, Inc. | 73% | |
| GluBio Therapeutics | 72% | |
| Nurix Therapeutics, Inc. | 68% | |
Koutif Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 21, 2017 |
Koutif Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioMotiv | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2017
Led by BioMotiv
Koutif Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Koutif Therapeutics's valuation, stock price, and market status.